MDCG guidance for consultations of authorities on devices incorporating a medicinal product

Published date29 June 2020
Subject MatterMedical Devices,Life Sciences,EU,Consultation Periods,Belgium,Regulatory Oversight,Pharmaceutical Industry,Regulatory Requirements,European Medicines Agency (EMA)
AuthorFabien Roy
Law FirmHogan Lovells

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT